Another milestone in minimizing risks to mothers exposed to single-dose nevirapine for prevention of vertical transmission of HIV-1 to infants: what next?

Clin Infect Dis. 2010 Mar 15;50(6):909-11. doi: 10.1086/650746.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-HIV Agents / adverse effects*
  • Anti-HIV Agents / therapeutic use*
  • Didanosine / adverse effects
  • Didanosine / therapeutic use
  • Drug Resistance, Viral*
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / virology*
  • HIV-1 / drug effects*
  • HIV-1 / isolation & purification
  • Humans
  • Infant
  • Infant, Newborn
  • Mutation, Missense*
  • Nevirapine / adverse effects
  • Nevirapine / therapeutic use
  • Pregnancy
  • Zidovudine / adverse effects
  • Zidovudine / therapeutic use

Substances

  • Anti-HIV Agents
  • Zidovudine
  • Nevirapine
  • Didanosine